| For: | Lu YL, Li GL, Huang HL, Zhong J, Dai LC. Peroxisome proliferator-activated receptor-γ 34C>G polymorphism and colorectal cancer risk: A meta-analysis. World J Gastroenterol 2010; 16(17): 2170-2175 [PMID: 20440859 DOI: 10.3748/wjg.v16.i17.2170] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i17/2170.htm |
| Number | Citing Articles |
| 1 |
Jun Wang, Xufeng Guo, Pengbo Wu, Jia Song, Chuncui Ye, Shijie Yu, Jixiang Zhang, Weiguo Dong. Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: A meta-analysis. Gene 2013; 528(2) doi: 10.1016/j.gene.2013.07.014
|
| 2 |
Hassan R. Dhaini, Zeina Daher. Genetic polymorphisms of PPAR genes and human cancers: evidence for gene–environment interactions. Journal of Environmental Science and Health, Part C 2019; 37(3) doi: 10.1080/10590501.2019.1593011
|
| 3 |
Mingqi Li, Qi You, Xishan Wang. Association Between Polymorphism of the Tumor Necrosis Factor Alpha-308 Gene Promoter and Colon Cancer in the Chinese Population. Genetic Testing and Molecular Biomarkers 2011; 15(11) doi: 10.1089/gtmb.2011.0068
|
| 4 |
Yujun Wang, Chibo Liu. Quantitative evaluation of common polymorphism (rs1801282) in the PPARγ2 gene and hypertension susceptibility. Gene 2012; 502(2) doi: 10.1016/j.gene.2012.04.035
|
| 5 |
. 2015; doi: 10.70675/c93fe817z72bez4af5zbb57zebcc2a52d927
|
| 6 |
Mujeeb Zafar Banday, Aga Syed Sameer, Saniya Nissar. Genetic Polymorphism and cancer susceptibility. 2021; doi: 10.1007/978-981-33-6699-2_5
|
| 7 |
Meena K. Sakharkar, Babita Shashni, Karun Sharma, Sarinder K. Dhillon, Prabhakar R. Ranjekar, Kishore R. Sakharkar. Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer. PPAR Research 2013; 2013 doi: 10.1155/2013/109285
|
| 8 |
Jing Zhao, Zheng Zhi, Guangyao Song, Juan Wang, Chao Wang, Huijuan Ma, Xian Yu, Aixia Sui, Hongtao Zhang. Peroxisome Proliferator-Activated Receptor-Gamma Pro12Ala Polymorphism Could be a Risk Factor for Gastric Cancer. Asian Pacific Journal of Cancer Prevention 2015; 16(6) doi: 10.7314/APJCP.2015.16.6.2333
|
| 9 |
Xuemin Liang, Xiaohua Fan, Kanglian Tan, Li Zhang, Lisi Jian, Linchong Yu. Peroxisome proliferators-activated receptor gamma polymorphisms and colorectal cancer risk. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 2) doi: 10.4103/0973-1482.235346
|
| 10 |
Rong Xie, Shaobo Tang, Yanna Yang. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis. Journal of Diabetes and its Complications 2022; 36(10) doi: 10.1016/j.jdiacomp.2022.108261
|
| 11 |
Xiyong Bai. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis. Medical Science Monitor 2015; 21 doi: 10.12659/MSM.892849
|
| 12 |
Valerio Pazienza, Manlio Vinciguerra, Gianluigi Mazzoccoli. PPARs Signaling and Cancer in the Gastrointestinal System. PPAR Research 2012; 2012 doi: 10.1155/2012/560846
|
| 13 |
E. Theodoratou, Z. Montazeri, S. Hawken, G. C. Allum, J. Gong, V. Tait, I. Kirac, M. Tazari, S. M. Farrington, A. Demarsh, L. Zgaga, D. Landry, H. E. Benson, S. H. Read, I. Rudan, A. Tenesa, M. G. Dunlop, H. Campbell, J. Little. Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Colorectal Cancer. JNCI Journal of the National Cancer Institute 2012; 104(19) doi: 10.1093/jnci/djs369
|